StonvexLoading…
StonvexStonvexStonvexCore line items from ERII's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $9.71M | $134.99M | $68.12M | $36.12M |
Operating Income | $-14.86M | $23.89M | $-7.43M | $-11.09M |
Net Income | $-12.25M | $22.96M | $-3.95M | $-7.83M |
EPS (Diluted) | $-0.23 | $0.42 | $-0.07 | $-0.14 |
Total Assets | $208.99M | $231.51M | $209.65M | $212.28M |
Total Liabilities | $24.70M | $25.32M | $28.81M | $27.07M |
Cash & Equivalents | $50.12M | $48.08M | $47.10M | $57.05M |
Free Cash Flow OCF − CapEx | $20.22M | $17.44M | $11.03M | $14.50M |
Shares Outstanding | 52.08M | 52.81M | 52.98M | 53.68M |